NCT07761130

Brief Summary

The goal of this study is to learn if the Improving Healthand Lifestyle Programme (iHeLP) is feasible and acceptable to stroke survivors. The main questions it aims to answer are:

  • Is iHeLP feasible to deliver?
  • Is iHeLP acceptable to people who take part?
  • What effect does iHeLP have on the lifestyle behaviours of participants? Participants will:
  • Take part in the iHeLP intervention (consists of a one-to-one interview with the facilitator followed by six weekly group sessions with other stroke survivors)
  • Complete questionnaires about their lifestyle during the one-to-one interview and after the intervention.
  • Participate in a focus group to discuss their experiences and perceptions of iHeLP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 9, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 15, 2026

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

July 15, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

strokelifestylefeasibilitybehavior changebehaviour changesecondary prevention

Outcome Measures

Primary Outcomes (6)

  • Recruitment

    The total number of people screened and recruited to the study will be recorded, with the recruitment rate calculated as a percentage, with the number of people enrolled (numerator) over the number of eligible participants (denominator).

    During screening to enrollment

  • Retention

    Retention will be calculated as the proportion of individuals who, after enrolment, completed the intervention and all follow-up assessments.

    From enrollment to follow-up assessments (week 8)

  • Adherence to the intervention schedule

    Adherence to the intervention schedule will be assessed through recording participant attendance at all sessions, with reasons for non-attendance documented.

    During the intervention period (week 1 to week 8)

  • Intervention fidelity

    Intervention fidelity will be assessed by recording deviations from the intervention manual

    During the intervention period (week 1 to week 8)

  • Adverse events

    Any adverse events will be recorded during intervention or reported by participants during the study period

    During the intervention period (week 1 to week 8)

  • Acceptability

    The acceptability of intervention to participants will be evaluated quantitatively through a self-report questionnaire designed by the researchers, scored on a 5-point Likert scale. This questionnaire will be guided by the theoretical framework of acceptability and guidance for acceptability questionnaires of healthcare interventions, and encompass key concepts of acceptability relating to affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy. Focus groups with each intervention group will also be completed to develop a comprehensive understanding of the acceptability of the intervention.

    Follow-up assessments (week 8)

Secondary Outcomes (6)

  • Self-rated health.

    Baseline assessments (week 1) and follow-up assessments (week 8)

  • Physical activity levels

    Baseline assessments (week 1) and follow-up assessments (week 8)

  • Medication adherence

    Baseline assessments (week 1) and follow-up assessments (week 8)

  • Adherence to the Mediterranean diet

    Baseline assessments (week 1) and follow-up assessments (week 8)

  • Alcohol consumption

    Baseline assessments (week 1) to follow-up assessments (week 8)

  • +1 more secondary outcomes

Study Arms (1)

Intervention arm (iHeLP)

EXPERIMENTAL

Participants in this arm will receive the Improving Health and Lifestyle Programme (iHeLP) intervention.

Behavioral: The Improving Health and Lifestyle Programme (iHeLP)

Interventions

The Improving Health and Lifestyle Programme (iHeLP) is an evidence- and theory-informed secondary prevention intervention to support behaviour change and healthy lifestyle participation after stroke. Participants will complete a one-to-one interview (approximately 60 minutes) with the programme facilitator to establish health status and set personalised lifestyle goals. Participants then take part in six weekly group in-person sessions lasting approximately 2 hours each, with each intervention session consisting of six core components: skills training, education, physical activity participation, goal-setting, supported emotional self-regulation and peer learning.

Intervention arm (iHeLP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Community-dwelling
  • Adults (≥18 years of age)
  • Diagnosis of any type of stroke
  • Capacity to provide informed consent,
  • Score between 0 (no symptoms) to 3 (moderate disability) on the Modified Rankin Scale.

You may not qualify if:

  • Individuals with physician-confirmed contraindications for undertaking physical activity
  • Those with active dementia or delirium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Irish Heart Foundation

Dublin, Leinster, Ireland

Location

University of Limerick

Limerick, Munster, Ireland

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2026

First Posted

August 12, 2026

Study Start

February 9, 2026

Primary Completion

June 10, 2026

Study Completion

June 10, 2026

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

The anonymised individual participant data underlying the results reported in publications will be made available with a data dictionary.

Time Frame
Beginning August 2026 with no end date

Locations